Annual Operating Profit
$49.53 M
+$75.26 M+292.47%
31 December 2023
Summary:
ANI Pharmaceuticals annual operaing income is currently $49.53 million, with the most recent change of +$75.26 million (+292.47%) on 31 December 2023. During the last 3 years, it has risen by +$65.10 million (+418.11%). ANIP annual operating profit is now at all-time high.ANIP Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$19.69 M
-$25.22 M-456.26%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly operating income is currently -$19.69 million, with the most recent change of -$25.22 million (-456.26%) on 30 September 2024. Over the past year, it has dropped by -$35.09 million (-227.94%). ANIP quarterly operating profit is now -227.94% below its all-time high of $15.39 million, reached on 30 September 2023.ANIP Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$9.60 M
-$35.09 M-78.52%
30 September 2024
Summary:
ANI Pharmaceuticals TTM operating income is currently $9.60 million, with the most recent change of -$35.09 million (-78.52%) on 30 September 2024. Over the past year, it has dropped by -$36.23 million (-79.05%). ANIP TTM operating profit is now -81.75% below its all-time high of $52.60 million, reached on 31 March 2024.ANIP TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +292.5% | -227.9% | -79.0% |
| 3 y3 years | +418.1% | -452.9% | +239.3% |
| 5 y5 years | +40.1% | -368.8% | -70.4% |
ANIP Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +275.8% | -227.9% | +3.9% | -81.8% | +117.8% |
| 5 y | 5 years | at high | +275.8% | -227.9% | +3.9% | -81.8% | +117.8% |
| alltime | all time | at high | +197.3% | -227.9% | +20.7% | -81.8% | +117.2% |
ANI Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$19.69 M(-456.3%) | $9.60 M(-78.5%) |
| June 2024 | - | $5.53 M(-63.3%) | $44.69 M(-15.0%) |
| Mar 2024 | - | $15.05 M(+72.8%) | $52.60 M(+6.2%) |
| Dec 2023 | $49.53 M(-292.5%) | $8.71 M(-43.4%) | $49.53 M(+8.1%) |
| Sept 2023 | - | $15.39 M(+14.5%) | $45.83 M(+55.6%) |
| June 2023 | - | $13.44 M(+12.1%) | $29.46 M(+527.6%) |
| Mar 2023 | - | $11.99 M(+139.1%) | $4.69 M(-118.2%) |
| Dec 2022 | -$25.73 M(-8.6%) | $5.01 M(-612.5%) | -$25.73 M(-49.8%) |
| Sept 2022 | - | -$978.00 K(-91.4%) | -$51.24 M(-4.8%) |
| June 2022 | - | -$11.33 M(-38.6%) | -$53.83 M(+8.4%) |
| Mar 2022 | - | -$18.44 M(-10.0%) | -$49.66 M(+76.3%) |
| Dec 2021 | -$28.17 M(+80.9%) | -$20.50 M(+475.5%) | -$28.17 M(+308.7%) |
| Sept 2021 | - | -$3.56 M(-50.2%) | -$6.89 M(+1203.0%) |
| June 2021 | - | -$7.15 M(-334.9%) | -$529.00 K(-88.7%) |
| Mar 2021 | - | $3.04 M(+291.9%) | -$4.68 M(-69.9%) |
| Dec 2020 | -$15.57 M(-194.8%) | $777.00 K(-72.3%) | -$15.57 M(-25.7%) |
| Sept 2020 | - | $2.80 M(-124.8%) | -$20.94 M(+27.6%) |
| June 2020 | - | -$11.31 M(+44.2%) | -$16.42 M(-492.6%) |
| Mar 2020 | - | -$7.84 M(+70.6%) | $4.18 M(-74.5%) |
| Dec 2019 | $16.43 M(-53.5%) | -$4.60 M(-162.7%) | $16.43 M(-49.4%) |
| Sept 2019 | - | $7.33 M(-21.1%) | $32.47 M(-7.9%) |
| June 2019 | - | $9.29 M(+111.1%) | $35.25 M(+6.1%) |
| Mar 2019 | - | $4.40 M(-61.5%) | $33.22 M(-6.0%) |
| Dec 2018 | $35.36 M(+21.0%) | $11.45 M(+13.2%) | $35.36 M(+9.8%) |
| Sept 2018 | - | $10.11 M(+39.3%) | $32.20 M(+2.5%) |
| June 2018 | - | $7.26 M(+11.1%) | $31.41 M(+0.9%) |
| Mar 2018 | - | $6.54 M(-21.1%) | $31.14 M(+6.5%) |
| Dec 2017 | $29.23 M(+9.2%) | $8.28 M(-11.2%) | $29.23 M(+1.0%) |
| Sept 2017 | - | $9.33 M(+33.4%) | $28.93 M(+5.1%) |
| June 2017 | - | $6.99 M(+51.2%) | $27.52 M(+7.0%) |
| Mar 2017 | - | $4.63 M(-42.1%) | $25.72 M(-3.9%) |
| Dec 2016 | $26.76 M(-18.2%) | $7.98 M(+0.8%) | $26.76 M(+6.8%) |
| Sept 2016 | - | $7.92 M(+52.5%) | $25.05 M(-2.1%) |
| June 2016 | - | $5.19 M(-8.3%) | $25.58 M(-11.2%) |
| Mar 2016 | - | $5.67 M(-9.6%) | $28.80 M(-11.9%) |
| Dec 2015 | $32.70 M(+63.5%) | $6.27 M(-25.8%) | $32.70 M(-12.1%) |
| Sept 2015 | - | $8.45 M(+0.4%) | $37.20 M(+0.7%) |
| June 2015 | - | $8.41 M(-12.1%) | $36.95 M(+41.7%) |
| Mar 2015 | - | $9.57 M(-11.2%) | $26.08 M(+30.4%) |
| Dec 2014 | $20.01 M(+2127.8%) | $10.77 M(+31.4%) | $20.01 M(+57.6%) |
| Sept 2014 | - | $8.20 M(-433.3%) | $12.69 M(+139.3%) |
| June 2014 | - | -$2.46 M(-170.4%) | $5.30 M(+33.0%) |
| Mar 2014 | - | $3.50 M(+1.0%) | $3.99 M(-263.0%) |
| Dec 2013 | $898.00 K(-103.9%) | $3.46 M(+327.2%) | -$2.45 M(-74.4%) |
| Sept 2013 | - | $810.00 K(-121.5%) | -$9.54 M(-39.2%) |
| June 2013 | - | -$3.77 M(+28.3%) | -$15.69 M(-18.2%) |
| Mar 2013 | - | -$2.94 M(-19.1%) | -$19.18 M(-17.2%) |
| Dec 2012 | -$23.17 M(-54.5%) | -$3.64 M(-31.9%) | -$23.17 M(-17.0%) |
| Sept 2012 | - | -$5.33 M(-26.6%) | -$27.93 M(-21.6%) |
| June 2012 | - | -$7.27 M(+4.9%) | -$35.62 M(-14.0%) |
| Mar 2012 | - | -$6.93 M(-17.4%) | -$41.42 M(-18.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$50.93 M(+16.8%) | -$8.39 M(-35.6%) | -$50.93 M(-8.6%) |
| Sept 2011 | - | -$13.03 M(-0.3%) | -$55.70 M(+3.3%) |
| June 2011 | - | -$13.06 M(-20.5%) | -$53.92 M(+5.5%) |
| Mar 2011 | - | -$16.44 M(+24.9%) | -$51.09 M(+17.2%) |
| Dec 2010 | -$43.61 M(+13.5%) | -$13.17 M(+17.2%) | -$43.61 M(-21.1%) |
| Sept 2010 | - | -$11.24 M(+9.8%) | -$55.28 M(+13.0%) |
| June 2010 | - | -$10.24 M(+14.3%) | -$48.94 M(+13.0%) |
| Mar 2010 | - | -$8.96 M(-63.9%) | -$43.32 M(+12.7%) |
| Dec 2009 | -$38.43 M(+113.3%) | -$24.84 M(+407.0%) | -$38.43 M(+148.8%) |
| Sept 2009 | - | -$4.90 M(+6.0%) | -$15.44 M(-10.4%) |
| June 2009 | - | -$4.62 M(+13.7%) | -$17.23 M(-4.9%) |
| Mar 2009 | - | -$4.06 M(+118.5%) | -$18.13 M(+0.5%) |
| Dec 2008 | -$18.01 M(+107.5%) | -$1.86 M(-72.2%) | -$18.03 M(-0.8%) |
| Sept 2008 | - | -$6.69 M(+21.3%) | -$18.18 M(+33.3%) |
| June 2008 | - | -$5.51 M(+39.0%) | -$13.64 M(+26.8%) |
| Mar 2008 | - | -$3.97 M(+97.1%) | -$10.76 M(+24.0%) |
| Dec 2007 | -$8.68 M(-352.3%) | -$2.01 M(-6.3%) | -$8.68 M(-366.2%) |
| Sept 2007 | - | -$2.15 M(-18.4%) | $3.26 M(-28.2%) |
| June 2007 | - | -$2.63 M(+39.3%) | $4.54 M(-6.9%) |
| Mar 2007 | - | -$1.89 M(-119.0%) | $4.88 M(+41.8%) |
| Dec 2006 | $3.44 M(-137.0%) | $9.93 M(-1244.3%) | $3.44 M(-141.5%) |
| Sept 2006 | - | -$867.50 K(-62.2%) | -$8.28 M(-11.6%) |
| June 2006 | - | -$2.30 M(-31.0%) | -$9.37 M(-4.0%) |
| Mar 2006 | - | -$3.32 M(+85.5%) | -$9.76 M(+4.9%) |
| Dec 2005 | -$9.30 M(-24.2%) | -$1.79 M(-8.4%) | -$9.30 M(-20.6%) |
| Sept 2005 | - | -$1.96 M(-27.1%) | -$11.72 M(-7.8%) |
| June 2005 | - | -$2.68 M(-6.4%) | -$12.72 M(+0.4%) |
| Mar 2005 | - | -$2.87 M(-31.9%) | -$12.66 M(+3.2%) |
| Dec 2004 | -$12.27 M(+102.9%) | -$4.21 M(+42.5%) | -$12.27 M(+25.1%) |
| Sept 2004 | - | -$2.95 M(+12.3%) | -$9.80 M(+18.3%) |
| June 2004 | - | -$2.63 M(+6.4%) | -$8.29 M(+13.8%) |
| Mar 2004 | - | -$2.47 M(+41.6%) | -$7.29 M(+20.3%) |
| Dec 2003 | -$6.05 M(+58.7%) | -$1.75 M(+21.4%) | -$6.06 M(+28.3%) |
| Sept 2003 | - | -$1.44 M(-11.6%) | -$4.72 M(+15.6%) |
| June 2003 | - | -$1.63 M(+30.8%) | -$4.08 M(+3.2%) |
| Mar 2003 | - | -$1.24 M(+202.6%) | -$3.96 M(+3.7%) |
| Dec 2002 | -$3.81 M(+36.8%) | -$411.40 K(-48.6%) | -$3.82 M(-21.2%) |
| Sept 2002 | - | -$801.00 K(-46.7%) | -$4.85 M(+28.9%) |
| June 2002 | - | -$1.50 M(+36.2%) | -$3.76 M(+20.6%) |
| Mar 2002 | - | -$1.10 M(-23.4%) | -$3.12 M(+13.9%) |
| Dec 2001 | -$2.79 M(-19.0%) | -$1.44 M(-603.1%) | -$2.73 M(+34.1%) |
| Sept 2001 | - | $286.30 K(-133.3%) | -$2.04 M(-32.2%) |
| June 2001 | - | -$858.90 K(+19.0%) | -$3.01 M(-16.1%) |
| Mar 2001 | - | -$722.00 K(-3.0%) | -$3.58 M(+6.1%) |
| Dec 2000 | -$3.44 M(+114.2%) | -$744.40 K(+9.3%) | -$3.38 M(+28.3%) |
| Sept 2000 | - | -$680.90 K(-52.5%) | -$2.63 M(+34.9%) |
| June 2000 | - | -$1.43 M(+177.8%) | -$1.95 M(+131.5%) |
| Mar 2000 | - | -$516.20 K(+58.2%) | -$842.40 K(+158.2%) |
| Dec 1999 | -$1.60 M(-39.7%) | - | - |
| June 1999 | - | -$326.20 K | -$326.20 K |
| Dec 1998 | -$2.66 M | - | - |
FAQ
- What is ANI Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual operating profit year-on-year change?
- What is ANI Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly operating profit year-on-year change?
- What is ANI Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals TTM operating profit year-on-year change?
What is ANI Pharmaceuticals annual operaing income?
The current annual operating profit of ANIP is $49.53 M
What is the all time high annual operating profit for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual operaing income is $49.53 M
What is ANI Pharmaceuticals annual operating profit year-on-year change?
Over the past year, ANIP annual operaing income has changed by +$75.26 M (+292.47%)
What is ANI Pharmaceuticals quarterly operating income?
The current quarterly operating profit of ANIP is -$19.69 M
What is the all time high quarterly operating profit for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly operating income is $15.39 M
What is ANI Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, ANIP quarterly operating income has changed by -$35.09 M (-227.94%)
What is ANI Pharmaceuticals TTM operating income?
The current TTM operating profit of ANIP is $9.60 M
What is the all time high TTM operating profit for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high TTM operating income is $52.60 M
What is ANI Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, ANIP TTM operating income has changed by -$36.23 M (-79.05%)